The study of expression levels of DNA methylation regulators in patients affected with congenital heart defects (CHDs)
Birth Defects Research2022Vol. 114(7), pp. 228–237
Citations Over Time
Abstract
Lower expression of de novo methyltransferases, namely, DNMT3B and DNMT3A in CHD cases, may be an important contributor to the mechanism of CHD pathogenesis. Further studies with age-matched controls and analysis of global DNA methylation profile are required to investigate the proposed causal association.
Related Papers
- Hepatitis B virus infection in hepatocellular carcinoma tissues upregulates expression of DNA methyltransferases.(2015)
- → High expression of DNA methyltransferases in primary human medulloblastoma(2016)15 cited
- → Phosphorothioation of Oligonucleotides Strongly Influences the Inhibition of Bacterial (M.HhaI) and Human (Dnmt1) DNA Methyltransferases(2009)5 cited
- [The expression of DNA methyltransferase DNMT1, 3A and 3B in acute leukemia and myelodysplastic syndrome].(2003)
- Effects of Hydroquinone on the Expression of DNA Methyltransferase(2012)